-
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors
Wednesday, February 3, 2016 - 3:53pm | 296Read More...The Medicines Company (NASDAQ: MDCO) announced on Wednesday that it has appointed Dr. Alexander Denner to its Board of Directors. Denner is the Chief Investment Officer of Sarissa Capital Management, a registered investment advisor. Denner founded the firm in 2012 and prior to that he was a...
-
Why Is The Medicines Company Stock Falling? This Analyst May Have An Answer
Wednesday, July 29, 2015 - 2:53pm | 337Read More...Shares of The Medicines Company (NASDAQ: MDCO) tumbled more than 5 percent Wednesday after the company reported its second-quarter results before the market opened. Shares opened the day for trading at $32.77 and quickly moved lower to $31.08 before slightly rebounding. Umer Raffat, Evercore ISI's...
-
Medicines Co. Buys Heart Drug from Pfizer: BioBuzz (MDCO, PFE)
Wednesday, December 23, 2009 - 12:32pm | 133Read More...One man's trash is another man's treasure. For Medicines Co. (NASDAQ: MDCO) CEO Clive Meanwell, that's the motto to run a drug company. Tuesday night, Medicines Co. announced it had licensed an old -- and many thought discarded -- heart drug from Pfizer (NYSE: PFE). The drug, known as ApoA-I...
